Overactive bladder (OAB) is often treated with medications that block the cholinergic
receptors in the bladder (known as anticholinergics). The effect of this medication class on …

The Piezo channel family, including Piezo1 and Piezo2, includes essential
mechanosensitive transduction molecules in mammals. Functioning in the conversion of …

Metabolic syndrome (MetS) is defined by a group of cardiovascular risk factors, including
impaired glucose tolerance, central obesity, hypertension, and dyslipidemia. Overactive …

The urinary tract likely plays a role in the development of various urinary diseases due to the
recently recognized notion that urine is not sterile. In this mini review, we summarize the …

Overactive bladder syndrome is a chronic, disabling condition with physical, psychological
and social consequences that significantly affects the quality of life of millions of patients …

Results At 3 months, cure rates for frequency, urgency, nocturia and prolapse were
comparable. By the 6-month review, catastrophic failure commenced in the postmenopausal …

Purpose: PLUS investigated the efficacy and safety of mirabegron add-on therapy in men
with overactive bladder symptoms receiving tamsulosin for underlying lower urinary tract …

Overactive bladder (OAB) syndrome, including frequency, urgency, nocturia and urgency
incontinence, has a significantly negative impact on the quality-of-life scale (QoL) and can …

Aims Lower urinary tract symptoms (LUTS) can be classified into symptom syndromes based
on which symptoms are predominant. Overactive bladder (OAB) syndrome, a storage …

Background Overactive bladder (OAB) is a common clinical condition for which current drug
treatment comprises drugs blocking the cholinergic nerve supply, or augmenting the …